← Back to Search

Mind Body Bridging Group Session for Suicidal Thoughts

N/A
Waitlist Available
Led By William Marchand, MD
Research Sponsored by VA Salt Lake City Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects will be Veterans aged 18-80 admitted to Substance Abuse Residential Rehabilitation Treatment Program (SARRTP) with addictive disorders and/or co-occurring psychiatric disorder with suicide risk factors.
Subjects will be Veterans aged 18-70 with psychiatric and/or addictive disorders who are on the High Risk Suicide List because of suicidal ideations and/or behaviors.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly during the intervention, one-month post-intervention, three months post-intervention, six months post-intervention
Awards & highlights

Study Summary

This trial will compare the MBB-SI to TAU to see if the MBB-SI reduces SI and/or SRB's.

Eligible Conditions
  • Suicidal Thoughts
  • Mind-Body Bridging

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a Veteran aged 18-80 with an addiction or mental health issue and at risk of suicide, admitted to a rehab program.
Select...
I am a Veteran aged 18-70, at high risk of suicide due to my psychiatric or addictive disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly during the intervention, one-month post-intervention, three months post-intervention, six months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly during the intervention, one-month post-intervention, three months post-intervention, six months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in frequency and/or intensity of suicidal ideation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment As Usual with Mind-Body Bridging (TAU + MBB)Experimental Treatment1 Intervention
Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in consisting of three to eight 60-minute sessions that will occur consecutively. Each group will be led by a trained MBB facilitator. Participants will receive a workbook at the beginning of the training that contains an explanation of all the major concepts involved in Mind Body Bridging. The workbook has homework assignments to be completed daily between group sessions.
Group II: Treatment as Usual (TAU)Active Control1 Intervention
Participants assigned to Treatment As Usual (TAU) will receive the normal standard of care treatment from the Suicide Prevention Team and the Mental Health Service which may include individual therapy, group therapy, and/or medication therapy, all as decided by the individual and his/her doctor. Treatment as usual also includes monitoring by the Suicide Prevention Team.

Find a Location

Who is running the clinical trial?

VA Salt Lake City Health Care SystemLead Sponsor
24 Previous Clinical Trials
264,918 Total Patients Enrolled
Mind Body Bridging CharityUNKNOWN
William Marchand, MDPrincipal InvestigatorVA Salt Lake City HCS
1 Previous Clinical Trials
250 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025